![FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer](https://oncodaily.com/pub/uploads/2024/03/32681d3d-0c83-49e8-91ea-cef712176d6a-1280x720.jpeg)
Jun 22, 2024, 14:35
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
FDA Oncology shared on X:
“FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer.”
Source: FDA Oncology/X
Aug 14, 2024, 03:41